Tickernomics

10y

Historical Returns*:

SPY

27.80%

-5.98%

BHC.TO

SPY

32.66%

-73.08%

BHC.TO

SPY

108.59%

-74.66%

BHC.TO

SPY

302.52%

-94.74%

BHC.TO

*Assumes dividends reinvested

Market Stats:

Market Capitalization($MM)

Enterprise Value($MM)

Daily Volume(MM)

2774.64

23715.64

0.08

Valuation Metrics:

Price/Earnings Ratio

Price/Sales Ratio

Price/Book Value

FCF Yield(%)

Dividend Yield(%)

EV/EBITDA

-15.59

0.29

-11.47

33.56

0.00

9.16

Profitability Stats:

Operating Margin %(ttm)

Gross Profit %(ttm)

EBITDA Margin %(ttm)

12.67

72.27

27.03

Shareholder Value Creation:

Cost of Capital %(est)

ROIC %(ttm)

ROCE %(ttm)

Beta

8.0

-16.54

6.68

1.00

Other Earnings and Cash Flow Stats:

Bausch Health Companies Inc ( BHC.TO ) Net Income TTM ($MM) is -178.00

Bausch Health Companies Inc ( BHC.TO ) Operating Income TTM ($MM) is 1350.00

Bausch Health Companies Inc ( BHC.TO ) Owners' Earnings Annual ($MM) is 1437.69

Bausch Health Companies Inc ( BHC.TO ) Current Price to Owners' Earnings ratio is 2.04

Bausch Health Companies Inc ( BHC.TO ) EBITDA TTM ($MM) is 2639.00

Bausch Health Companies Inc ( BHC.TO ) EBITDA Margin is 27.03%

Capital Allocation:

Bausch Health Companies Inc ( BHC.TO ) has paid 0.00 dividends per share and bought back -1.409709 million shares in the past 12 months

Bausch Health Companies Inc ( BHC.TO ) has increased its debt by 5053.7958095802 million USD in the last 12 months

Capital Structure:

Bausch Health Companies Inc ( BHC.TO ) Interest-bearing Debt ($MM) as of last quarter is 21660

Bausch Health Companies Inc ( BHC.TO ) Annual Working Capital Investments ($MM) are -96

Bausch Health Companies Inc ( BHC.TO ) Book Value ($MM) as of last quarter is -242

Bausch Health Companies Inc ( BHC.TO ) Debt/Capital as of last quarter is -1844%

Other Balance Sheet Stats:

Bausch Health Companies Inc ( BHC.TO ) has 719 million in cash on hand as of last quarter

Bausch Health Companies Inc ( BHC.TO ) has 4506 million of liabilities due within 12 months, and long term debt 21660 as of last quarter

Bausch Health Companies Inc ( BHC.TO ) has 368 common shares outstanding as of last quarter

Bausch Health Companies Inc ( BHC.TO ) has 0 million USD of preferred stock value

Academic Scores:

Bausch Health Companies Inc ( BHC.TO ) Altman Z-Score is 0.10 as of last quarter

Bausch Health Companies Inc ( BHC.TO ) Piotroski Score is 5.00 as of last quarter

Corporate Governance:

Bausch Health Companies Inc ( BHC.TO ) largest shareholder is owning shares at 0.00 ($MM) value

(an insider) shares of Bausch Health Companies Inc ( BHC.TO ) for the amount of $ on

11.08% of Bausch Health Companies Inc ( BHC.TO ) is held by insiders, and 71.41% is held by institutions

Bausch Health Companies Inc ( BHC.TO ) went public on 1970-01-01

About Bausch Health Companies Inc ( BHC.TO ) :

Bausch Health Companies Inc., together with its subsidiaries, develops, manufactures, and markets a range of pharmaceutical, medical device, and over-the-counter (OTC) products primarily in the therapeutic areas of eye health, gastroenterology, and dermatology. The company operates through five segments: Salix, International, Solta Medical, Diversified Products, and Bausch + Lomb. The Salix segment provides gastroenterology products in the United States. The International segment offers Solta products, branded and generic pharmaceutical products, OTC products, and medical device products, and Bausch + Lomb products in Canada, Europe, Asia, Latin America, Africa, and the Middle East. The Solta Medical segment offers medical devices. The Diversified Products segment offers pharmaceutical products in the areas of neurology and other therapeutic classes, as well as generic, dermatological, and dentistry products in the United States. The Bausch + Lomb segment offers products with a focus on the vision care, surgical, and ophthalmic pharmaceuticals products. The company was formerly known as Valeant Pharmaceuticals International, Inc. and changed its name to Bausch Health Companies Inc. in July 2018. Bausch Health Companies Inc. is headquartered in Laval, Canada.

DISCLAIMER

This web site and its creators are not certified financial advisors. All opinions/suggestions expressed on this website should not be treated as specific inducement to make a particular investment or follow a particular strategy, but only as an expression of an opinion.The Company doesn't warrant the information provided on the website for its completeness or accuracy, and it should not be relied upon as such. The Company is not under any obligation to update or correct any information provided on this website.The content of this website is published in the United States of America and persons who access it agree to do so in accordance with applicable U.S. law.Past performance is not indicative of future results. The Company doesn't guarantee any specific outcome or profit. You should be aware of the real risk of loss in following any strategy or investment discussed on this website.Strategies or investments discussed may fluctuate in price or value. Investors may get back less than invested. Investments or strategies mentioned on this website may not be suitable for you. This material does not take into account your particular investment objectives,financial situation or needs and is not intended as recommendations appropriate for you. You must make an independent decision regarding investments or strategies mentioned on this website. Before acting on information on this website, you should consider whether it is suitable for your particular circumstances and strongly consider seeking advice from your own financial or investment adviser.